Media

Learn more about us in our featured news stories and insights into the work that we do.

News Press Releases Locus Insights

August 12, 2024

Locus Biosciences Announces Positive Results from Part 1 of ELIMINATE Phase 2 Trial of the Engineered Bacteriophage Therapy LBP-EC01 Published in The Lancet Infectious Diseases

Learn More
February 1, 2024

Antimicrobial Resistance: Multiple Threats, Multiple Responses

Learn More
February 1, 2024

Locus milestone unlocks more BARDA cash

Learn More
January 26, 2024

Locus Biosciences receives $23.9 million from BARDA for CRISPR-engineered therapy trial

Learn More
January 26, 2024

BARDA backs Locus phage therapy for resistant E coli

Learn More
January 26, 2024

Locus Biosciences Receives $23.9 Million Boost for Bacteriophage Therapy Advancement in UTI Treatment

Learn More
January 26, 2024

BARDA Funds Next Stage of CRISPR-Based Bacteriophage Therapy

Learn More
January 23, 2024

Locus Biosciences Announces $23.9 Million in Funding from BARDA to Support First Phase 2 Trial of CRISPR-engineered Bacteriophage Therapy

Learn More
January 11, 2024

The burden of inflammatory bowel disease (IBD) in the US

Learn More
October 16, 2023

Phages and Synthetic Biology Team Up to Tackle Antimicrobial Resistance

Learn More